Journal Report

Vascular Pharmacology

Download PDF
Journal Information
Journal Title
Vascular Pharmacology
Publisher
Elsevier Inc.
ISSN
1537-1891
E-ISSN
1879-3649
Database
SCOPUS
Domain
Health Sciences, Life Sciences, Physical Sciences, Social Sciences
Classification History
Year A+ A B C
2026 ✓ ✓
2025 ✓ ✓
2024 ✓ ✓
2023 ✓ ✓
2021/2022 ✓ ✓
2020 ✓ ✓
2019 ✓ ✓
2018 ✓
A journal may have more than one classification in the same year. All recorded classifications are displayed.
Recent Articles
NLRP3 inflammasome–NETosis crosstalk in hypertensive cardiac remodeling: Cellular mechanisms and therapeutic opportunities
Jun Xie, Dandan Meng, Jiahao Weng et al.
2026-12 Vol. 165 Pages 107705
DOI: 10.1016/j.vph.2026.107705
The potential of targeting adenosine 5′-monophosphate-activated protein kinase to treat peripheral artery disease: Evidence from preclinical mouse models
Callan D. Wesley, Shivshankar Thanigaimani, Jonathan S. Oakhill et al.
2026-12 Vol. 165 Pages 107708
DOI: 10.1016/j.vph.2026.107708
Epigenetic regulation of vascular smooth muscle cell plasticity in vascular injury, repair, and aging
Xi-Long Zheng, Jiaxing Sun, Hao Yin et al.
2026-12 Vol. 165 Pages 107712
DOI: 10.1016/j.vph.2026.107712
Integrative genetic analyses for drug repurposing identify emodin as a candidate modulator of STAT3 signaling in abdominal aortic aneurysm
Yingjie Liu, Zhijun Xu, Lin Deng et al.
2026-12 Vol. 165 Pages 107711
DOI: 10.1016/j.vph.2026.107711
A pathway-level analysis reveals oxidative and inflammatory vascular stress signatures associated with VEGF inhibition
Jean Carlos Lipreri da Silva, Grace Whelan, Filipe de Farias F. Martins et al.
2026-12 Vol. 165 Pages 107718
DOI: 10.1016/j.vph.2026.107718
Beyond catecholamine escalation: Receptor desensitization and endogenous vasopressor failure, and extracorporeal circuit biocompatibility after cardiopulmonary bypass—A narrative review
Ignazio Condello, Michele Dell'Aquila, Salvatore Condello et al.
2026-12 Vol. 165 Pages 107707
DOI: 10.1016/j.vph.2026.107707
Ticagrelor pretreatment and angiographic no-reflow in STEMI: a multicentre observational study
Martino Pepe, Eduardo Urgesi, Rocco Tritto et al.
2026-12 Vol. 165 Pages 107715
DOI: 10.1016/j.vph.2026.107715
Pan-peroxisome proliferator-activated receptor agonist IVA337 alleviates secondary lymphedema via inhibiting TGFβ/SMAD2/3 signaling pathway
Jingjing Pang, Long Nguyen Hoang Do, Esteban Delgado et al.
2026-12 Vol. 165 Pages 107693
DOI: 10.1016/j.vph.2026.107693
Targeting phospholipid signaling in arterial diseases: mechanisms and therapeutic opportunities
Cai-Xia Hu, Xuan Wang, Mi Wang et al.
2026-12 Vol. 165 Pages 107721
DOI: 10.1016/j.vph.2026.107721
Multiple manifestations of coronary microvascular dysfunction in a double-hit mouse model of HFpEF
Grzegorz Kwiatkowski, Urszula Tyrankiewicz, Sylwester Mosiołek et al.
2026-12 Vol. 165 Pages 107686
DOI: 10.1016/j.vph.2026.107686
Articles retrieved from Crossref.
Green Journals | https://www.green-journals.com | info@green-journals.com
Printed: November 8, 2026 09:21